Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis.
Caner Feyzi DemirFerhat BALGETiREthemoglu OzlemDürdane Bekar AksoyFiliz DemirdögenSuleyman Serdar KocaMehmet Fatih Yetkinİrem TaşcıPublished in: Archives of rheumatology (2021)
Ocrelizumab therapy led to a prominent decrease in the frequency of FMF attacks, alleviated functional impairment, and improved quality of life in MS+FMF patients.